Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis. [GOC:ai]
Negative regulation of dendrite morphogenesis is a complex process that involves a tightly regulated interplay of various molecular mechanisms, including transcription factors, signaling pathways, and cytoskeletal dynamics. This process ensures proper formation, branching, and growth of dendrites, which are the branched extensions of neurons responsible for receiving signals from other neurons.
The negative regulation of dendrite morphogenesis involves suppressing the formation, growth, and branching of dendrites. This is crucial for ensuring proper neuronal development and connectivity, preventing excessive branching and ensuring the formation of a well-organized neuronal network.
Here are some key molecular mechanisms involved in the negative regulation of dendrite morphogenesis:
* **Transcriptional Regulation:** Specific transcription factors can repress the expression of genes involved in dendrite growth and branching. These transcription factors can bind to regulatory regions of genes and prevent their transcription, thereby reducing the production of proteins essential for dendrite morphogenesis.
* **Signaling Pathway Modulation:** Signaling pathways, such as the Wnt, Notch, and BMP pathways, play crucial roles in regulating dendrite development. Negative regulation can occur by inhibiting the activity of these pathways or by activating their inhibitory components.
* **Cytoskeletal Dynamics:** The cytoskeleton provides structural support and plays a vital role in dendrite morphogenesis. Negative regulation can involve inhibiting the polymerization of actin filaments, which are essential for dendrite extension, or promoting the depolymerization of microtubules, which are responsible for dendrite branching.
* **Microtubule Stability:** The stability of microtubules is critical for dendrite development, and negative regulation can involve destabilizing microtubules, preventing their polymerization, or promoting their depolymerization.
* **Protein Degradation:** Proteins involved in dendrite morphogenesis can be degraded through the ubiquitin-proteasome system, effectively reducing their levels and inhibiting their activity.
* **Cell-Cell Interactions:** Interactions between neurons and glial cells, which are non-neuronal cells that support and protect neurons, can influence dendrite morphogenesis. Negative regulation can involve inhibiting these interactions or modifying the signaling molecules involved.
* **Environmental Factors:** External factors, such as growth factors, neurotransmitters, and environmental stress, can also influence dendrite development. Negative regulation can involve the suppression of these factors or their downstream signaling pathways.
The negative regulation of dendrite morphogenesis is a highly dynamic process that is influenced by a wide range of molecular mechanisms and environmental cues. This intricate regulation ensures the proper formation and function of neuronal networks, contributing to the complexity and diversity of the nervous system.'
"
Protein | Definition | Taxonomy |
---|---|---|
Short transient receptor potential channel 5 | A short transient receptor potential channel 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UL62] | Homo sapiens (human) |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | A protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209] | Homo sapiens (human) |
14-3-3 protein eta | A 14-3-3 protein eta that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q04917] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ym 58483 | |||
arsenic trioxide | |||
tacrolimus | tacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. | macrolide lactam | bacterial metabolite; immunosuppressive agent |
tamoxifen | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator | |
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
apigenin | Chamomile: Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia. | trihydroxyflavone | antineoplastic agent; metabolite |
luteolin | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist | |
kaempferol | 7-hydroxyflavonol; flavonols; tetrahydroxyflavone | antibacterial agent; geroprotector; human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; plant metabolite | |
galangin | 5,7-dihydroxyflavonol: antimicrobial from the twigs of Populus nigra x Populus deltoides; structure in first source galangin : A 7-hydroxyflavonol with additional hydroxy groups at positions 3 and 5 respectively; a growth inhibitor of breast tumor cells. | 7-hydroxyflavonol; trihydroxyflavone | antimicrobial agent; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; plant metabolite |
myricetin | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite | |
cyclosporine | ramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MF | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
r18 peptide | R18 peptide: a 20-mer peptide, derived from a phage library, that binds 14-3-3 tau protein; amino acid sequence in first source | ||
englerin a | cinnamate ester; glycolate ester; guaiane sesquiterpenoid | antineoplastic agent; metabolite |